With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

2.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

3.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

4.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

5.

ALK-positive lung cancer trial results show unprecedented progression-free survival.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot